Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk

Genome Medicine

Volumn 4, Issue 7, 2012, Pages

  Huang, Ying ^a   Ballinger, Dennis G ^b   Stokowski, Renee ^c   Beilharz, Erica ^b   Robinson, Jennifer G ^d   Liu, Simin ^e   Robinson, Randal D ^f   Henderson, Victor W ^g   Rossouw, Jacques E ^h   Prentice, Ross L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Complete Genomics Inc ^*  (United States)

^c Aria Diagnostics   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f University of Texas Health Science Center at San Antonio   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CALCIUM; ESTROGEN; GESTAGEN; PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9; PROTEIN; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIET THERAPY; FEMALE; FOLLOW UP; GENOTYPE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84871502638     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm358     Document Type: Article

References (43)

1. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TFC, McCarroll SA, Visscher PM. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753. 10.1038/nature08494, 2831613, 19812666.
2. Hata J, Matsuda K, Ninomiya T, Yonemoto K, Matsushita T, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Iida M, Kiyohara Y, Nakamura Y, Kubo M. Functional snp in an sp1-binding site of agtrl1 gene is associated with susceptibility to brain infarction. Hum Mol Genet 2007, 16:630-639.
3. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Sueishi K, Iida M, Nakamura Y, Kiyohara Y. A nonsynonymous SNP in PRKCH (protein kinase C η) increases the risk of cerebral infarction. Nat Genet 2007, 39:212-217. 10.1038/ng1945, 17206144.
4. Matarin M, Brown WM, Scholz S, Simon-Sanchez J, Fung H, Hernandez D, Gibbs JR, DeVrieze FW, Crews C, Britton A, Langefeld CD, Brott TG, Brown RD, Worrall BB, Frankel M, Silliman S, Case LD, Singleton A, Hardy JA, Rich SS, Meschia JF. A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol 2007, 6:414-420. 10.1016/S1474-4422(07)70081-9, 2613843, 17434096.
5. Bilguvar K, Yasuno K, Niemela M, Ruigrok YM, von Und Zu Fraunberg M, van Duijn CM, van den Berg LH, Mane S, Mason CE, Choi M, Gaal E, Bayri Y, Kolb L, Arlier Z, Ravuri S, Ronkainen A, Tajima A, Laakso A, Hata A, Kasuya H, Koivisto T, Rinne J, Ohman J, Breteler MM, Wijmenga C, State MW, Rinkel GJ, Hernesniemi J, Jaaskelainen JE, Palotie A, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 2008, 40:1472-1477. 10.1038/ng.240, 2682433, 18997786.
6. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, Kostulas K, Kuhlenbaumer G, Bevan S, Jonsdottir T, Bjarnason H, Saemundsdottir J, Palsson S, Arnar DO, Holm H, Thorgeirsson G, Valdimarsson EM, Sveinbjornsdottir S, Gieger C, Berger K, Wichmann HE, Hillert J, Markus H, Gulcher JR, Ringelstein EB, Kong A, Dichgans M, Gudbjartsson DF, Thorsteinsdottir U, Stefansson K. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 2008, 64:402-409. 10.1002/ana.21480, 18991354.
7. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, Gulcher J, Mathiesen EB, Njolstad I, Nyrnes A, Wilsgaard T, Hald EM, Hveem K, Stoltenberg C, Kucera G, Stubblefield T, Carter S, Roden D, Ng MC, Baum L, So WY, Wong KS, Chan JC, Gieger C, Wichmann HE, Gschwendtner A, Dichgans M, Kuhlenbaumer G, Berger K, Ringelstein EB, et al. A sequence variant in zfhx3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009, 41:876-878. 10.1038/ng.417, 2740741, 19597491.
8. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, Debette S, Lumley T, Folsom AR, van den Herik EG, Bos MJ, Beiser A, Cushman M, Launer LJ, Shahar E, Struchalin M, Du Y, Glazer NL, Rosamond WD, Rivadeneira F, Kelly-Hayes M, Lopez OL, Coresh J, Hofman A, DeCarli C, Heckbert SR, Koudstaal PJ, Yang Q, Smith NL, Kase CS, et al. Genomewide association studies of stroke. N Engl J Med 2009, 360:1718-1728. 10.1056/NEJMoa0900094, 2768348, 19369658.
9. Yamada Y, Fuku N, Tanaka M, Aoyagi Y, Sawabe M, Metoki N, Yoshida H, Satoh K, Kato K, Watanabe S, Nozawa Y, Hasegawa A, Kojima T. Identification of celsr1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis 2009, 207:144-149. 10.1016/j.atherosclerosis.2009.03.038, 19403135.
10. Lanktree MB, Dichgans M, Hegele RA. Advances in genomic analysis of stroke: what have we learned and where are we headed?. Stroke 2010, 41:825-832. 10.1161/STROKEAHA.109.570523, 20167918.
11. Meschia JF. Stroke genome-wide association studies: the large numbers imperative. Stroke 2010, 41:579-580. 10.1161/STROKEAHA.109.576769, 2885710, 20185773.
12. Self SG, Longton G, Kopecky KJ, Liang KY. On estimating HLA/disease association with application to a study of aplastic anemia. Biometrics 1991, 47:53-61. 10.2307/2532495, 2049513.
13. Piegorsch WW, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 1994, 13:153-162. 10.1002/sim.4780130206, 8122051.
14. Vittinghoff E, Bauer DC. Case-only analysis of treatment-covariate iterations in clinical trials. Biometrics 2006, 62:769-776. 10.1111/j.1541-0420.2006.00511.x, 16984319.
15. Prentice RL, Huang Y, Hinds DA, Peters U, Pettinger M, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, Caan B, Ballinger DG. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarker Prev 2009, 18:3079-3085.
16. Prentice RL, Huang Y, Hinds DA, Peters U, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, Caan B, Ballinger DG. Variation in the FGFR2 gene and the effects of a low-fat dietary pattern on invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2010, 19:74-79. 10.1158/1055-9965.EPI-09-0663, 2806599, 20056625.
17. Huang Y, Ballinger DG, Dai JY, Peters U, Hinds DA, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, McTiernan A, Rohan T, Prentice RL. Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Med 2011, 3:42. 10.1186/gm258, 3218816, 21702935.
18. Prentice RL, Anderson GL. The Women's Health Initiative: lessons learned. Annu Rev Public Health 2007, 29:131-150.
19. The Women's Health Initiative Study Group Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998, 19:61-109. The Women's Health Initiative Study Group.
20. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, . Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. 10.1001/jama.288.3.321, 12117397, Writing Group for the Women's Health Initiative Investigators.
21. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A, . WHI Investigators Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003, 289:3243-3253. 10.1001/jama.289.24.3243, 12824205, WHI Investigators.
22. Wassertheil-Smoller S, Hendrix S, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb D, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw J. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative. JAMA 2003, 289:2673-2684. 10.1001/jama.289.20.2673, 12771114.
23. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, , et al. Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291:1701-1712. Women's Health Initiative Steering Committee.
24. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J, . WHI Investigators Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006, 113:2425-2434. 10.1161/CIRCULATIONAHA.105.594077, 16702472, WHI Investigators.
25. Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzysk R, Allison M, Ockene J, Sarto G, Rossouw JE. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol 2009, 170:12-23. 10.1093/aje/kwp115, 2733042, 19468079.
26. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Philips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative randomized controlled dietary modification trial. JAMA 2006, 295:655-666. 10.1001/jama.295.6.655, 16467234.
27. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M, . Women's Health Initiative Investigators Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846-854. 10.1161/CIRCULATIONAHA.106.673491, 17309935, Women's Health Initiative Investigators.
28. Kooperberg C, LeBlanc M. Increasing the power of identifying gene-gene interactions in genome-wide association studies. Genet Epidemiol 2008, 32:255-263. 10.1002/gepi.20300, 2955421, 18200600.
29. Dai J, LeBlanc M, Kooperberg C, Prentice RL. On two-stage hypothesis testing procedures via asymptotically independent statistics. Biometrika
30. Dai JY, Logsdon B, Huang Y, Hsu L, Reiner A, Prentice RL, Kooperberg C. Simultaneous testing for marginal genetic association and gene-environment interaction in genome-wide association studies. Am J Epidemiol 176:164-173.
31. Hays JL, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, Rossouw JE. The Women's Health Initiative recruitment methods and results. Ann Epidmiol 2002, 13:S18-S77.
32. Saccone SS, Hinrich AL, Saccone NL, Chase GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau O, Swan GE, Goate AM, Rutter J, Bertelsen S, Fox L, Fugman D, Martin NG, Montgomery GW, Wang JC, Ballinger DG, Rice JP, Bierut LJ. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2006, 16:36-49. 10.1093/hmg/ddl438, 2270437, 17135278.
33. Markus H. Genes for stroke. J Neurol Neurosurg Psychiatry 2004, 75:1229-1231. 10.1136/jnnp.2004.036202, 1739201, 15314104.
34. Bersano A, Bresolin E, Bresolin N, Candelise L. Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat 2008, 29:776-795. 10.1002/humu.20666, 18421701.
35. Pruissen DMO, Slooter AJC, Rosendaal FR, van der Graaf Y, Algra A. Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke. Blood 2008, 111:1282-1286.
36. Katayama H, Pacznesny S, Prentice RL, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J, Rossouw J, Jackson R, Hsia J, Chlebowski R, Manson J, Hanash S. Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med 2009, 1:47.1-47.16.
37. Pitteri SJ, Hanash SM, Aragaki A, Amon L, Chen L, Busald Buson T, Paczesny S, Katayama H, Wang H, Johnson MM, Zhang Q, McIntosh M, Wang P, Kooperberg C, Rossouw JE, Jackson R, Manson JE, Hsia J, Liu S, Martin L, Prentice RL. Postmenopausal estrogen and progestin effects on the serum proteome. Genome Med 2009, 1:121.1-121.14.
38. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal component analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909. 10.1038/ng1847, 16862161.
39. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.
40. Kooperberg C, Cushman M, Hsia J, Robinson JG, Aragaki AK, Lynch JK, Baird AE, Johnson KC, Kuller LH, Beresford SAA, Rodriguez B. Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials. PLoS Clin Trials 2007, 2:e28. 10.1371/journal.pctr.0020028, 1891725, 17571161.
41. Abboud S, Karhunen PJ, Lütjohann D, Goebeler S, Luoto T, Friedrichs S, Lehtimaki T, Pandolfo M, and Laaksonen R. Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. PLoS ONE 2007, 2:e1043. 10.1371/journal.pone.0001043, 2002510, 17940607.
42. Costet P, Krempf M, Cariou B. PCSK9 and LDL cholesterol: unraveling the target to design the bullet. Trends Biochem Sci 2008, 33:426-434. 10.1016/j.tibs.2008.06.005, 18672372.
43. Peterson AS, Fong LG, Young SG. PCSK9 function and physiology (commentary). J Lipid Res 2008, 49:1152-1156. 10.1194/jlr.E800008-JLR200, 2386899, 18375913.